Anzeige
Mehr »
Samstag, 19.07.2025 - Börsentäglich über 12.000 News
Kupfer en mass...: 10 Prozent-Kupfer an der Oberfläche! - Diese Entdeckung könnte zur heißesten Kupferstory des Jahres werden!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A1XFUX | ISIN: IL0011313900 | Ticker-Symbol: GPH
Lang & Schwarz
18.07.25 | 07:00
6,500 Euro
-100,00 % -6,500
Branche
Biotechnologie
Aktienmarkt
Sonstige
1-Jahres-Chart
GALMED PHARMACEUTICALS LTD Chart 1 Jahr
5-Tage-Chart
GALMED PHARMACEUTICALS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
6,4006,60018.07.

Aktuelle News zur GALMED Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
22.05.Galmed GAAP EPS of -$0.62 beats by $0.276
GALMED Aktie jetzt für 0€ handeln
22.05.Galmed Pharmaceuticals Ltd.: Galmed Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update484TEL AVIV, Israel, May 22, 2025 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (NASDAQ: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company...
► Artikel lesen
22.05.Galmed Pharmaceuticals Ltd. - 6-K, Report of foreign issuer1
13.05.Galmed Pharmaceuticals Ltd. - 6-K, Report of foreign issuer1
13.05.Galmed Pharmaceuticals Ltd.: Galmed Reports Significant Anti-Fibrotic Effects of Aramchol in PSC Models137Aramchol, an SCD1 inhibitor, significantly attenuates and prevents biliary fibrosis in mouse models of primary sclerosing cholangitis (PSC) Aramchol treatment...
► Artikel lesen
06.05.Galmed Pharmaceuticals Ltd. - 6-K, Report of foreign issuer6
06.05.Galmed Pharmaceuticals Ltd.: Galmed Announces First Time Results in Oncology Studies: Aramchol Significantly Enhances Bayer's Regorafenib Effect in GI Cancer Models725Results from studies at Virginia Commonwealth University (VCU) show that an Aramchol and Bayer's Regorafenib drug combination significantly reduced hepatic tumor...
► Artikel lesen
02.05.Galmed, Entomus Partner to Introduce Sublingual Semaglutide2
28.04.Galmed Pharmaceuticals Ltd. - 6-K, Report of foreign issuer3
17.04.Galmed Pharmaceuticals Ltd. - 6-K, Report of foreign issuer2
15.04.Galmed Pharmaceuticals Ltd.: Galmed Unveils Novel Pharmacodynamic Blood Markers for Aramchol, the Most Clinically Advanced SCD1 Inhibitor146Analysis of blood samples from patients treated with Aramchol in ARMOR (Ph3 MASH Study) provides new and important insights into the biochemical and physiological...
► Artikel lesen
10.04.Galmed Reports Positive Part 1 Results From AM-001 Study Of Aramchol Meglumine1
10.04.Galmed Pharmaceuticals Ltd. - 6-K, Report of foreign issuer1
10.04.Galmed Pharmaceuticals Ltd.: Galmed Announces Positive Part 1 Results from the AM-001 Study of Aramchol Meglumine, an Enhanced Formulation of the Most Clinically Advanced SCD1 Inhibitor142- AM-001 Study represents a pivotal milestone in Galmed's transition to Aramchol Meglumine, an improved formulation of its lead compound in advanced clinical development...
► Artikel lesen
02.04.Galmed Pharmaceuticals Ltd. - 20-F, Annual and transition report of foreign private issuers1
20.03.Galmed Pharmaceuticals Ltd. - 6-K, Report of foreign issuer2
18.09.24Pre-market Movers: Portage Biotech, Veea, Intuitive Machines, Applied Therapeutics, Galmed Pharmaceuticals1.817BEIJING (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.30 A.M. ET).In the Green Portage Biotech Inc. (PRTG) is up over 179% at...
► Artikel lesen
17.09.24Pre-market Movers: Galmed Pharmaceuticals, Wheeler Real Estate Investment Trust, Netcapital, Allarity Therapeutics, Relmada Therapeutics973SANTA CLARA (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 07.40 A.M. ET).In the Green Galmed Pharmaceuticals Ltd. (GLMD) is up over...
► Artikel lesen
30.08.24XFRA GPH: AUSSETZUNG/SUSPENSION544DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILGALMED PHARMACEUT.IS...
► Artikel lesen
30.08.24XFRA CAPITAL ADJUSTMENT INFORMATION - 30.08.2024820Das Instrument AWQ NO0010607971 AWILCO LNG NK -,10 EQUITY wird cum Kapitalmassnahme gehandelt am 30.08.2024 und ex Kapitalmassnahme am 02.09.2024 The instrument AWQ NO0010607971 AWILCO LNG NK -,10 EQUITY...
► Artikel lesen
20 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1